We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Shenzhen YHLO Biotech Co., Ltd.

Shenzhen YHLO Biotech Co., Ltd. (YHLO) is an immunoassay solutions company that specializes in developing, manufactur... read more Featured Products: More products

Download Mobile App

YHLO Unveils New iBC 900 Automated Chemistry Analyzer

By LabMedica International staff writers
Posted on 07 Feb 2024
Print article
Image: The new iBC 900 automated chemistry analyzer unveiled at Medlab Middle East 2024 (Photo courtesy of YHLO)
Image: The new iBC 900 automated chemistry analyzer unveiled at Medlab Middle East 2024 (Photo courtesy of YHLO)

YHLO (Shenzhen, China) is unveiling its latest innovations and breakthroughs in IVD at Medlab Middle East in Dubai, taking place February 5-8, 2024.

YHLO is launching the new iBC 900 automated chemistry analyzer which offers multidirectional modular expansion and compatibility with iFlash 3000, making it a game-changer for medical laboratories worldwide. At Medlab Middle East 2024, YHLO is showcasing its iFlash series of chemiluminescence immunoassay analyzers, including the iFlash 1200, iFlash 1800, and iFlash 3000. iFlash 1200 is the latest addition to the iFlash family, offering an unparalleled workstation to low-mid volume testing laboratories, especially with limited floor space. On the other hand, iFlash 1800 offers better efficiency and reliability with fewer outsourced samples, improved in-house controlled quality, and higher throughput. The iFlash 3000 chemiluminescence immunoassay analyzer is designed not only to meet the fundamental needs of large laboratories, but also to improve their efficiency, productivity, and quality.

In addition, YHLO is highlighting the VISION ESR analyzer that redefines the analysis of Erythrocyte Sedimentation Rate (ESR). The ESR is a nonspecific indicator of inflammation in the body. When there is inflammation or infection present, certain proteins in the blood cause red blood cells to stick together and settle more rapidly. By measuring the rate at which red blood cells settle, the VISION ESR analyzer provides valuable information about the inflammatory response, aiding in the diagnosis and monitoring of various conditions. It provides a real ESR curve and Bio-Rad control assigned value and delivers results in 20 minutes with excellent Westergren correlation. It uses primary EDTA tubes and offers batch and STAT test modes with a state-of-the-art design for the least maintenance.

Related Links:

Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
POCT Fluorescent Immunoassay Analyzer
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV

Print article


Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Molecular Diagnostics

view channel
Image: Protein ‘signatures’ obtained via a blood sample can be used to predict the onset of 67 diseases (Photo courtesy of Queen Mary University of London)

Protein Signatures in Blood Can Predict Risk of Developing More Than 60 Diseases

Measuring specific proteins to diagnose conditions like heart attacks, where troponin is tested, is a well-established clinical practice. Now, new research highlights the broader potential of protein measurements... Read more


view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more


view channel
Image: The Simplexa C. auris direct kit is a real-time polymerase chain reaction assay run on the LIAISON MDX instrument (Photo courtesy of Diasorin)

Novel Molecular Test to Help Prevent and Control Multi Drug-Resistant Fungal Pathogen in Healthcare Settings

Candida auris (C. auris) is a rapidly emerging multi drug-resistant fungal pathogen that is commonly found in healthcare environments, where it presents a challenge due to its ability to asymptomatically... Read more


view channel
Image: The tool can improve precision oncology by accurately predicting molecular subtypes and therapy responses (Photo courtesy of Shutterstock)

Computational Tool Integrates Transcriptomic Data for Improved Breast Cancer Diagnosis and Treatment

Breast cancer is the most commonly diagnosed cancer globally, presenting in various subtypes that require precise identification for effective, personalized treatment. Traditionally, cancer subtyping has... Read more


view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.